DOXYCYCLINE CALCIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for doxycycline calcium and what is the scope of freedom to operate?
Doxycycline calcium
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for DOXYCYCLINE CALCIUM
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 5 |
Patent Applications: | 382 |
DailyMed Link: | DOXYCYCLINE CALCIUM at DailyMed |
Recent Clinical Trials for DOXYCYCLINE CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Aksaray University | Phase 4 |
Lund University Hospital | Phase 4 |
Edward Lain, MD | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for DOXYCYCLINE CALCIUM
US Patents and Regulatory Information for DOXYCYCLINE CALCIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | VIBRAMYCIN | doxycycline calcium | SUSPENSION;ORAL | 050480-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |